Revvity Total Long-Term Assets 2010-2025 | RVTY

Revvity total long-term assets from 2010 to 2025. Total long-term assets can be defined as the sum of all assets classified as non-current
  • Revvity total long-term assets for the quarter ending June 30, 2025 were $10.043B, a 3.19% decline year-over-year.
  • Revvity total long-term assets for 2024 were $10.043B, a 4.93% decline from 2023.
  • Revvity total long-term assets for 2023 were $10.564B, a 2.56% decline from 2022.
  • Revvity total long-term assets for 2022 were $10.841B, a 13.68% decline from 2021.
Revvity Annual Total Long-Term Assets
(Millions of US $)
2024 $10,043
2023 $10,564
2022 $10,841
2021 $12,560
2020 $5,721
2019 $5,164
2018 $4,741
2017 $4,892
2016 $3,087
2015 $3,133
2014 $3,059
2013 $2,902
2012 $2,930
2011 $2,973
2010 $2,124
2009 $2,175
Revvity Quarterly Total Long-Term Assets
(Millions of US $)
2025-03-31 $10,043
2024-12-31 $10,043
2024-09-30 $10,321
2024-06-30 $10,266
2024-03-31 $10,373
2023-12-31 $10,564
2023-09-30 $10,508
2023-06-30 $10,695
2023-03-31 $10,843
2022-12-31 $10,841
2022-09-30 $10,707
2022-06-30 $12,082
2022-03-31 $12,394
2021-12-31 $12,560
2021-09-30 $12,649
2021-06-30 $6,479
2021-03-31 $6,088
2020-12-31 $5,721
2020-09-30 $5,190
2020-06-30 $5,105
2020-03-31 $5,043
2019-12-31 $5,164
2019-09-30 $4,941
2019-06-30 $5,061
2019-03-31 $4,839
2018-12-31 $4,741
2018-09-30 $4,697
2018-06-30 $4,755
2018-03-31 $4,892
2017-12-31 $4,892
2017-09-30 $3,193
2017-06-30 $3,171
2017-03-31 $3,224
2016-12-31 $3,087
2016-09-30 $3,151
2016-06-30 $3,115
2016-03-31 $3,161
2015-12-31 $3,133
2015-09-30 $2,958
2015-06-30 $3,012
2015-03-31 $3,006
2014-12-31 $3,059
2014-09-30 $2,812
2014-06-30 $2,856
2014-03-31 $2,873
2013-12-31 $2,902
2013-09-30 $2,903
2013-06-30 $2,905
2013-03-31 $2,911
2012-12-31 $2,930
2012-09-30 $2,949
2012-06-30 $2,903
2012-03-31 $2,956
2011-12-31 $2,973
2011-09-30 $2,472
2011-06-30 $2,520
2011-03-31 $2,218
2010-12-31 $2,124
2010-09-30 $2,270
2010-06-30 $2,222
2010-03-31 $2,136
2009-12-31 $2,175
2009-09-30 $2,208
2009-06-30 $2,126
2009-03-31 $2,078
Sector Industry Market Cap Revenue
Medical Medical Services $11.202B $2.755B
Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $145.316B 26.95
CVS Health (CVS) United States $75.446B 9.38
Elevance Health (ELV) United States $64.396B 8.66
Cencora (COR) United States $55.472B 19.30
DiDi Global (DIDIY) China $25.980B 27.60
Labcorp Holdings (LH) United States $21.919B 17.30
Natera (NTRA) United States $18.843B 0.00
BioMerieux (BMXMF) France $17.068B 0.00
ICON (ICLR) Ireland $15.316B 14.74
EUROFINS SCIENT (ERFSF) Luxembourg $14.929B 0.00
CochLear (CHEOY) Australia $13.403B 0.00
Solventum (SOLV) United States $12.763B 13.51
Medpace Holdings (MEDP) United States $12.728B 33.68
Viatris (VTRS) United States $10.868B 3.73
Avantor (AVTR) United States $9.533B 13.85
Sonic Healthcare (SKHHY) Australia $9.208B 0.00
Charles River Laboratories (CRL) United States $8.791B 17.23
HealthEquity (HQY) United States $8.281B 36.27
Caris Life Sciences,�Inc (CAI) United States $6.884B 0.00
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $5.109B 30.08
BrightSpring Health Services (BTSG) United States $3.600B 33.03
Sotera Health (SHC) United States $3.489B 19.82
Surgery Partners (SGRY) United States $2.876B 37.40
Organon (OGN) United States $2.592B 2.75
Concentras Parent (CON) United States $2.576B 14.89
GeneDx Holdings (WGS) United States $2.423B 93.31
Alignment Healthcare (ALHC) United States $2.346B 0.00
Progyny (PGNY) United States $1.989B 43.77
PACS (PACS) United States $1.792B 0.00
GoodRx Holdings (GDRX) United States $1.789B 35.79
Premier (PINC) United States $1.739B 13.20
Ardent Health (ARDT) United States $1.525B 6.50
Teladoc Health (TDOC) United States $1.439B 0.00
Establishment Labs Holdings (ESTA) $1.228B 0.00
Pediatrix Medical (MD) United States $1.088B 8.28
Ryman Healthcare (RYHTY) New Zealand $0.970B 0.00
QDM (QDMI) Hong Kong, SAR China $0.875B 300.00
Agilon Health (AGL) United States $0.824B 0.00
AMN Healthcare Services Inc (AMN) United States $0.753B 7.05
CareDx (CDNA) United States $0.712B 11.12
Embecta (EMBC) United States $0.662B 4.46
Nutex Health (NUTX) United States $0.513B 7.77
So-Young (SY) China $0.513B 0.00
InnovAge Holding (INNV) United States $0.506B 0.00
LifeMD (LFMD) United States $0.494B 0.00
Omada Health (OMDA) $0.478B 0.00
SBC Medicals (SBC) United States $0.477B 0.00
Sonida Senior Living (SNDA) United States $0.467B 0.00
Auna S.A (AUNA) Luxembourg $0.457B 10.28
COMPASS Pathways (CMPS) United Kingdom $0.406B 0.00
Enhabit (EHAB) United States $0.344B 28.29
Oncology Institute (TOI) United States $0.336B 0.00
Performant Healthcare (PHLT) United States $0.286B 0.00
Beauty Health (SKIN) United States $0.222B 0.00
Pheton Holdings (PTHL) China $0.204B 0.00
DocGo (DCGO) United States $0.152B 24.83
Sera Prognostics (SERA) United States $0.118B 0.00
Ascend Wellness Holdings (AAWH) United States $0.086B 0.00
KindlyMD (NAKA) United States $0.077B 0.00
Biodesix (BDSX) United States $0.061B 0.00
NeueHealth (NEUE) United States $0.060B 0.00
IceCure Medical (ICCM) Israel $0.060B 0.00
ModivCare (MODV) United States $0.044B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.042B 0.00
Basel Medical Group (BMGL) Singapore $0.041B 0.00
OSR Holdings (OSRH) United States $0.018B 0.00
Intelligent Bio Solutions (INBS) United States $0.011B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
BioNexus Gene Lab (BGLC) $0.008B 0.00
XWELL (XWEL) United States $0.006B 0.00
Aclarion (ACON) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00